Parallel Advisors’s GeneDx Holdings WGS Stock Holding History

Parallel Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.88K	Buy	+42	New	+$2.39K	﹤0.01%	3420
2026 Q1	–	Sell	-4	Closed	-$520	–	3964
2025 Q4	$520	Hold	4	–	–	﹤0.01%	3396
2025 Q3	$431	Buy	4 +3	+300%	+$327	﹤0.01%	3351
2025 Q2	$49	Buy	+1	New	+$79	﹤0.01%	3495
2025 Q1	–	Sell	-3	Closed	-$231	–	3684
2024 Q4	$231	Buy	+3	New	+$210	﹤0.01%	3355
2021 Q3	–	Sell	-102	Closed	-$47K	–	3286
2021 Q2	$47K	Buy	102 +45	+79%	+$19.3K	﹤0.01%	1277
2021 Q1	$28K	Buy	+57	New	+$29.6K	﹤0.01%	1450

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Parallel Advisors's WGS Position: Q2 2026 in Review

Parallel Advisors opened a new position in GeneDx Holdings (WGS) in Q2 2026: 42 shares worth $2.88K. The stake represents ﹤0.01% of the portfolio and ranks #3420 among its holdings. This is a return to the name: Parallel Advisors previously reported a position in WGS as recently as Q4 2025.

Parallel Advisors first reported a position in WGS in Q1 2021 and has held it in 7 quarters since. The position peaked at $47K in Q2 2021. 222 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Parallel Advisors held 42 shares of GeneDx Holdings worth $2.88K as of Q2 2026.
GeneDx Holdings was a new Parallel Advisors position in Q2 2026.
GeneDx Holdings made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3420 holding.
Parallel Advisors first reported a position in GeneDx Holdings in Q1 2021 and has held it in 7 quarters since.
Parallel Advisors's GeneDx Holdings position peaked at $47K in Q2 2021.
222 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.